Nasdaq GlobeNewswire

InnoStudio Continues To Push Chemistry Towards The Stars

Del

Space Chemistry Special Session to be held at International Astronautical Congress for first time

 

BUDAPEST, Hungary and BOSTON, May 10, 2018 (GLOBE NEWSWIRE) -- InnoStudio is pleased to announce that its proposal for holding a Special Session on Space Chemistry at the 69th International Astronautical Congress entitled "Space Chemistry: a Key to Fostering Space Exploration" has been accepted. This is the first time that a special session on this topic will be held at such a prestigious event. The congress will take place in Bremen, Germany between the 1st and 5th October 2018.  The above special session will be held as part of the technical programme. We believe that the acceptance of this topic as a special session greatly emphasizes the importance of Space Chemistry for the future of the Space Industry.

IAC2018 Special Sessions are to supplement the regular technical programme of the congress and provide a sample of the state-of-the-art research and development in both academia and industry in special, novel, challenging and emerging topics in the field of space. Special Sessions emphasize multi-disciplinary and transversal aspects, as well as cutting-edge topics of space exploration.

The list of accepted Special Sessions can be found at http://www.iafastro.org/events/iac/iac- 2018/technical-programme/special-sessions/.

We are also happy to announce that InnoStudio's experts will give a presentation at the 3rd Space Chemistry Symposium - "Chemistry in Space & Past, Present & Future", which will be held on the 254th ACS National Meeting & Exposition between 19th and 23rd August 2018 in Boston, US.

The topics of the symposium will cover a wide range of pioneering chemistry technologies from space perspectives, including flow chemistry, nanomaterials and new platforms for microgravity research onboard the International Space Station. These innovations are expected to make an essential contribution towards facilitating space exploration missions and human expeditions.

Finally, a perspective article written by InnoStudio's space experts was published in the Journal of Flow Chemistry. The paper summarizes the state of the art of space chemistry, analyzes the suitability of flow chemistry in an extraterrestrial environment, and discusses some of the challenges and opportunities in space chemistry.

Read the article here: https://akademiai.com/doi/pdf/10.1556/1846.2017.00033

For more information please contact Richard Jones, CEO: richard.jones@innostudio.org

About InnoStudio Inc.

InnoStudio Inc. was founded in 2013 as a spin-off of Cominnex Inc. The companies belong to Darholding, which is a leading innovation house specialized on innovative spin-out companies. The three pillars of success are: a strong scientific background, a wide network of relationships with top companies and a special management approach.

InnoStudio Inc. is specialized in innovating on high risk, high gain fields with high importance such as:

· Nanotechnology: applying dynamic flow systems for generating nanoparticles, primarily for life science and chemistry related fields. e.g. Innostudio formulates first-tier agrochemical substances in collaboration with Agrothetis Inc.

· Artificial Intelligence and Chemometrics: adapting them for developing software solutions needed by sister corporations in the Darholding network and other users for pharma and bioscience related discovery, flow chemistry, microfluidics and nanotechnology.

· Improving bioavailability of natural products: adapting complex physicochemical solutions, including nanotechnology, for enhancing and optimizing skin penetration of natural products in aromatherapy, cosmetics and other flavour and fragrance fields.

· Space Chemistry: bringing experimental chemistry to space by incubating a research and development team of specialists.

Together with two other companies of the Darholding network, ThalesNano Inc. and ComInnex Inc.  the Space Chemistry Studio of InnoStudio is working on the Space Chemistry Project for shaping the future of chemistry in space. The Space Chemistry Project was founded by the Flow Chemistry Society on Switzerland in 2014 for bringing chemistry to the space. Today it has more than 40 members from 5 continents. (http://spaceflow.org/)




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: InnoStudio Inc. via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

WillScot Announces Closing of Warrant Exchange Offer11.12.2018 22:05Pressemelding

BALTIMORE, Dec. 11, 2018 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”) (NASDAQ: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced the closing of its previously announced exchange offer (the “Exchange Offer”) relating to certain outstanding warrants issued in 2015 (the “Warrants”). Under the terms of the Exchange Offer, each Warrant holder had the opportunity to receive 0.18182 shares of WillScot Class A Common Stock, par value $0.0001 per share (“Common Stock”), for each Warrant tendered by the holder and exchanged pursuant to the Exchange Offer. As of the closing of the Exchange Offer on December 11, 2018, 45,131,827 outstanding Warrants were properly tendered and not withdrawn in the Exchange Offer. 45,031,827 of the Warrants tendered were public warrants, representing approximately 89% of the public warrants, and approximately 100,000 Warrants tendered were private warrant

DoubleVerify and InMobi Unite to Combat Mobile App Fraud11.12.2018 18:02Pressemelding

Partnership brings mobile app fraud prevention to advertisers globally NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- DoubleVerify ("DV"), the leading independent provider of marketing measurement software and analytics, today announced a partnership with InMobi, a global provider of enterprise platforms for marketers. As part of the partnership, DoubleVerify will provide always-on fraud filtering and measurement for mobile in-app advertising campaigns across the InMobi Exchange globally. The integration with InMobi covers pre-bid targeting for all InMobi Exchange impressions within the leading mobile in-app platform, as well as monitoring of post-bid fraud activity, such as spoofing – enabling InMobi to continuously refine the quality of its mobile ad inventory. “DV’s partnership with InMobi demonstrates our commitment to provide consistent, comprehensive quality coverage for global brand advertisers,” said Matt McLaughlin, COO at DoubleVerify. “With ad spend increasingly concentrated in

Claroty Announces Major Enhancements to Market-Leading Industrial Cybersecurity Platform11.12.2018 15:00Pressemelding

Groundbreaking multispectral data acquisition and network segmentation capabilities provide deeper OT network visibility and reduce risk for industrial enterprises and critical infrastructure providers NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Claroty, the leader in operational technology (OT) network protection, today announced several significant enhancements to its award-winning Continuous Threat Detection product and technology integrations with several leading industrial automation, network infrastructure and cybersecurity providers. Already the industry’s most complete industrial control systems (ICS) cybersecurity platform, this release incorporates new functionality to provide even more “extreme” visibility into ICS networks and help industrial enterprises decrease the risk of a cyberattack. The latest release of Claroty Continuous Threat Detection provides a large number of significant enhancements including: Virtual Zones and OT Network Segmentation – an innovative approach

INN Launches Battery Metals Channel11.12.2018 15:00Pressemelding

The new battery metals channel is designed to educate investors with original content and expert insight on the growing battery metals industry. VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Investing News Network (INN) announces the launch of its battery metals channel. Responding to the growth and evolution of the battery metals market, this channel will host news, educational content and expert opinions on the lithium, cobalt, graphite, vanadium and manganese market segments. “INN has been a trusted source of information on the lithium, cobalt, graphite, vanadium and manganese markets for nearly a decade, and is excited to bring these sectors together under the battery metals umbrella,” said Nick Smith, CEO and publisher at INN. “Through connections with experts, our leading team of experienced writers creates original, insightful content on battery metals. INN educates investors in the industry by providing information they may never have access to on their own,” S

Galimedix Therapeutics Appoints Industry Veteran, Hermann Russ, M.D., Ph.D., Chief Scientific Officer11.12.2018 14:30Pressemelding

KENSINGTON, Md. and SHORASHIM, Israel, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Galimedix Therapeutics, which is developing new solutions for ophthalmic and neurodegenerative diseases, announced the appointment of Hermann Russ, M.D., Ph.D., as its chief scientific officer, effective December 1, 2018. Dr. Russ invented the use of the company’s lead molecule GAL-101/MRZ-99030 for the treatment of degenerative diseases of the retina, including glaucoma and dry macular degeneration. He is also co-inventor of the so-called “trigger effect” of GAL-101/MRZ-99030 and GAL-102/MRZ 14042, which is a unique reverse prion-like self-propagation mechanism of action important for the company’s eye drop and oral treatment regimens. “We are gratified that Dr. Russ is joining the Galimedix management team, as his knowledge in the field, as well as intimate experience with the compound, have already proven instrumental in the development of our company to date,” commented Andrew Pearlman, Ph.D., CEO of Galimedix

Farmako: Cannabis distributor to become gateway to Europe11.12.2018 10:00Pressemelding

Company is first to apply for a licence in the United Kingdom AAA-Team pushes to become gateway to Europe Company first to apply for distribution licences in UK Support of Canadian LP to obtain EU-GMP Focus on research and development FRANKFURT, Germany, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The Frankfurt-based pharmaceutical company Farmako is a research-based pharmaceutical company that distributes medical cannabis. The company is active in all European markets that have created a legal basis for cannabinoid therapies. It is the first company for medical Cannabis pursue distribution licences in multiple European countries. Fort hat, it will rely on EU-GMP certified suppliers. The German market for medical cannabis is estimated at 19.1 million euros in 2018 and at 200 million Euros by 2019. For 2028, experts expect a market volume for medical cannabis of 7.8 billion euros in Germany, an increase by a factor of 400. The number of patients for cannabinoid therapies in Germany has grown from

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom